[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

Year

Day

October 26, 2017
Cancer Care Chronicles

Where Is the Road Map for Glioblastoma?

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3073
Original Investigation

Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3470

This study determines whether 70-gene signature assay findings are associated with physicians’ adjuvant treatment recommendations among patients with early breast cancer.

Brief Report

Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3168

This biomarker study examines the efficacy of irinotecan plus panitumumab in patients with advanced colorectal cancer whose tumors had high HER3 messenger RNA expression.

JAMA Oncology Clinical Challenge

Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3180

A woman in her 80s with a history of recurrent oral cancer was diagnosed with squamous cell carcinoma located at the margin of a palatal graft; surveillance imaging reveals metabolic activity in her left vocal cord. What is your diagnosis?

Research Letter

Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel–Lindau Disease

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3428

This study evaluates the natural history of von Hippel–Lindau disease–associated pancreatic lesions to determine the factors associated with pancreatic neuroendocrine tumor phenotype and prognosis.

Comment & Response

Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence?

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3349

Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence?—Reply

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3352
Correction

Error in Kaplan-Meier Curves

Abstract Full Text
free access
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.4131

Incorrect Hazard Ratio in Figure 2

Abstract Full Text
free access
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.4136
October 19, 2017
Viewpoint

Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal Cancer

Abstract Full Text
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3323

This Viewpoint examines consideration of human epidermal growth factor receptor 2 as a biomarker in metastatic CRC.

Original Investigation

Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival

Abstract Full Text
has audio
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3326

This cohort study assesses the association of locoregional surgery at diagnosis for small intestine neuroendocrine tumors with survival among Swedish patients.

Brief Report

“Job Lock” Among Long-term Survivors of Childhood CancerA Report From the Childhood Cancer Survivor Study

Abstract Full Text
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3372

This cross-sectional survey study quantifies the prevalence of self-reported “job lock” in a sample of full-time employed childhood cancer survivors and their siblings participating in the Childhood Cancer Survivor Study.

Research Letter

Changes in Insurance Coverage Among Cancer Patients Under the Affordable Care Act

Abstract Full Text
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3176

This analysis uses SEER Medicaid data to quantify changes in health insurance coverage under the Affordable Care Act among nonelderly patients newly diagnosed with cancer.

Comment & Response

Brain Metastases in Lung Cancer With Targetable MutationsShould We Allow Targeted Treatment in Prognostic Indices?

Abstract Full Text
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2016.7022

Brain Metastases in Lung Cancer With Targetable Mutations—Reply

Abstract Full Text
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3375
Correction

Errors in Table

Abstract Full Text
free access
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3889
JAMA Oncology Patient Page

Complementary and Alternative Medicine in Cancer Care

Abstract Full Text
free access
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3120
October 12, 2017
Cancer Care Chronicles

History of Lymphoma

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.2962
Original Investigation

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3290

This cohort study examines the prognostic role of CD8+ T lymphocytes for survival among women with epithelial ovarian cancer.

Brief Report

HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3159

This study compared response to ketoconazole treatment among patients with castration-resistant prostate cancer who had 0, 1, or 2 HSD3B1 variant alleles.

Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3164

This cohort study evaluates whether the HSD3B1 (1245C) allele is associated with worse clinical outcomes from androgen-deprivation therapy for biochemical recurrence after radiotherapy.

Invited Commentary

HSD3B1—A Predictive Biomarker in Advanced Prostate Cancer

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3158
Comment & Response

All Thiopurines Are Equal but Some Thiopurines Are More Equal Than Others

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.0740

All Thiopurines Are Equal But Some Thiopurines Are More Equal Than Others—Reply

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3369
October 9, 2017
Editorial

Death by Gun Violence—A Public Health Crisis

Abstract Full Text
free access
JAMA Oncol. Published online October 9, 2017. doi:10.1001/jamaoncol.2017.4357
October 5, 2017
Editorial

Adjuvant Ipilimumab for Melanoma—The $1.8 Million per Patient Regimen

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.3123
Original Investigation

The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National LevelResults From the Global Burden of Disease Study 2015

Abstract Full Text
open access
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.3055

This data analysis of the Global Burden of Disease 2015 study on primary liver cancer reports incidence, mortality, and disability-adjusted life-years for 195 countries or territories from 1990 to 2015, and presents global, regional, and national estimates on the burden of liver cancer.

Brief Report

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant ChemotherapyA Pooled Analysis From 2 Randomized Clinical Trials

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.2899

This pooled analysis of 2 randomized clinical trials evaluates the association of DNA mismatch repair status with disease-free survival in patients with stage III colon cancer treated with FOLFOX.

Comment & Response

Difficulties in Defining and Measuring Cancer-Related Fatigue

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.3355

Difficulties in Defining and Measuring Cancer-Related Fatigue—Reply

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.3358
Poetry and Oncology

A Last Draw From the Boneyard

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.2915
×